- Home
- LANV vs ME Comparison
LANV vs ME Comparison
Compare LANV & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANV
- ME
- Stock Information
- Founded
- LANV 2015
- ME 2006
- Country
- LANV China
- ME United States
- Employees
- LANV N/A
- ME N/A
- Industry
- LANV Blank Checks
- ME Precision Instruments
- Sector
- LANV Finance
- ME Health Care
- Exchange
- LANV Nasdaq
- ME Nasdaq
- Market Cap
- LANV 219.4M
- ME 98.7M
- IPO Year
- LANV N/A
- ME N/A
- Fundamental
- Price
- LANV $1.85
- ME $3.39
- Analyst Decision
- LANV
- ME Hold
- Analyst Count
- LANV 0
- ME 1
- Target Price
- LANV N/A
- ME $9.40
- AVG Volume (30 Days)
- LANV 92.6K
- ME 219.4K
- Earning Date
- LANV 02-19-2025
- ME 02-05-2025
- Dividend Yield
- LANV N/A
- ME N/A
- EPS Growth
- LANV N/A
- ME N/A
- EPS
- LANV N/A
- ME N/A
- Revenue
- LANV $409,961,427.00
- ME $193,260,000.00
- Revenue This Year
- LANV N/A
- ME $21.93
- Revenue Next Year
- LANV $10.45
- ME $17.31
- P/E Ratio
- LANV N/A
- ME N/A
- Revenue Growth
- LANV N/A
- ME N/A
- 52 Week Low
- LANV $0.91
- ME $2.66
- 52 Week High
- LANV $3.78
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- LANV 46.31
- ME 44.56
- Support Level
- LANV $1.69
- ME $3.15
- Resistance Level
- LANV $2.09
- ME $4.18
- Average True Range (ATR)
- LANV 0.24
- ME 0.26
- MACD
- LANV -0.04
- ME 0.05
- Stochastic Oscillator
- LANV 25.97
- ME 29.46
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.